Clinical Trial Update: Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide [NA]

View source ↗

Summary

A clinical trial update on Revita DMR evaluating safety and efficacy for maintaining body weight in people with obesity who have already achieved at least 15% w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Revita DMR

Snippet

Sponsor: Fractyl Health Inc. | Conditions: Obesity, Weight Change Trajectory | NA | Status: ACTIVE_NOT_RECRUITING